Obtain vaginal culture with species identification and consider non-albicans Candida or alternative diagnoses
When fluconazole fails to relieve intravaginal itching and white discharge, you must obtain a vaginal culture with species identification before proceeding with further treatment 1, 2. The failure of a single 150 mg fluconazole dose suggests either non-albicans Candida species (particularly C. glabrata), fluconazole-resistant C. albicans, or an alternative diagnosis entirely.
Immediate Diagnostic Steps
Confirm the diagnosis with microscopy and culture:
- Perform a wet mount with 10% potassium hydroxide to visualize yeast/hyphae
- Check vaginal pH (should be 4.0-4.5 for candidiasis; higher pH suggests bacterial vaginosis or trichomoniasis)
- Send vaginal culture for species identification and antifungal susceptibility testing 1, 2
The symptoms and signs of vulvovaginal candidiasis are nonspecific—less than 50% of women with genital itching actually have candidiasis 1, 3. White discharge with itching could represent bacterial vaginosis, trichomoniasis, or other conditions 4.
Treatment Algorithm Based on Culture Results
If Candida albicans is confirmed:
For severe or persistent symptoms, use fluconazole 150 mg every 72 hours for 2-3 doses 1. This extended regimen achieves superior clinical and mycologic cure rates compared to single-dose therapy in complicated cases 5.
If C. glabrata is identified:
C. glabrata is inherently resistant to standard azole doses. First-line treatment is intravaginal boric acid 600 mg in gelatin capsules daily for 14 days 1. This is a strong recommendation with low-quality evidence but represents the most effective available option.
Alternative options if boric acid is unavailable:
- Nystatin intravaginal suppositories 100,000 units daily for 14 days 1
- Topical 17% flucytosine cream ± 3% amphotericin B cream for 14 days (requires compounding) 1
If culture is negative or microscopy shows no yeast:
Consider alternative diagnoses:
- Bacterial vaginosis: milky discharge, pH >4.5, positive whiff test, clue cells 4
- Trichomoniasis: frothy discharge, inflammatory changes (requires culture or DNA probe as wet mount has high false-negative rate) 4
- Atrophic vaginitis: if postmenopausal or hypoestrogenic state 4
- Contact dermatitis or other vulvar conditions 6
Critical Pitfalls to Avoid
Do not continue empiric fluconazole without confirming the diagnosis—this leads to treatment failure and delays appropriate therapy 1, 3
Do not assume recurrent symptoms represent the same infection without proper examination and testing 6
Recognize that fluconazole-resistant C. albicans is emerging in women with prolonged azole exposure, though still rare 1, 7
Multivariate analysis shows non-albicans Candida predicts significantly reduced response regardless of therapy duration 5—species identification is essential, not optional
If Recurrent Vulvovaginal Candidiasis (≥4 episodes/year)
After confirming the diagnosis and achieving initial cure with 10-14 days of induction therapy, prescribe fluconazole 150 mg weekly for 6 months as maintenance therapy 1. This achieves symptom control in >90% of patients, though 40-50% will relapse after stopping 1.
The key message: Stop treating blindly and get a culture with species identification now 1, 2. Treatment failure after fluconazole demands microbiologic confirmation before proceeding.